University of Birmingham – Continuing Confidence in Concept
Lead Research Organisation:
University of Birmingham
Department Name: UNLISTED
Abstract
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
Technical Summary
The Confidence in Concept scheme is a key part of MRC’s translational research strategy and provides annual awards to institutions, to be used flexibly to support the earliest stages of multiple translational research projects. The award can be used by the institution to support a number of preliminary-stage translational projects. The projects supported should aim to provide sufficient preliminary data to establish the viability of an approach –– before seeking more substantive funding. It is intended to accelerate the transition from discovery research to translational development projects by supporting preliminary work or feasibility studies to establish the viability of an approach.
Organisations
Publications
Azoidis I
(2018)
The role of extracellular vesicles in biomineralisation: current perspective and application in regenerative medicine.
in Journal of tissue engineering
Description | DRAKE Foundation Award |
Amount | £170,316 (GBP) |
Organisation | University of Birmingham |
Sector | Academic/University |
Country | United Kingdom |
Start | 01/2019 |
Description | Developmental Pathway Funding Scheme |
Amount | £1,173,918 (GBP) |
Organisation | Medical Research Council (MRC) |
Sector | Public |
Country | United Kingdom |
Start | 03/2023 |
End | 02/2027 |
Description | Impact of chronic intermittent hypoxia on atrial resting membrane potential and Nav1.5 channel function: A new mechanism for causing atrial fibrillation |
Amount | £203,196 (GBP) |
Funding ID | PG/17/30/32961 |
Organisation | British Heart Foundation (BHF) |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 10/2017 |
End | 07/2021 |
Description | Instructive acellular tissue engineering (IATE) |
Amount | £273,280 (GBP) |
Funding ID | EP/S016589/1 |
Organisation | Engineering and Physical Sciences Research Council (EPSRC) |
Sector | Public |
Country | United Kingdom |
Start | 08/2019 |
End | 07/2021 |
Description | Internally Funded PhD Studentship |
Amount | £45,000 (GBP) |
Organisation | University of Birmingham |
Sector | Academic/University |
Country | United Kingdom |
Start |
Description | MRC Confidence in Concept (Round 6) |
Amount | £46,964 (GBP) |
Funding ID | 21451 |
Organisation | Medical Research Council (MRC) |
Sector | Public |
Country | United Kingdom |
Start | 07/2018 |
End | 11/2020 |
Description | MRC MR/R011230/1 |
Amount | £1,849,101 (GBP) |
Funding ID | MR/R011230/1-MRC and MR/R011230/1-EQUIPM |
Organisation | Medical Research Council (MRC) |
Sector | Public |
Country | United Kingdom |
Start | 10/2018 |
End | 10/2023 |
Description | Rugby Football Union |
Amount | £26,000 (GBP) |
Organisation | University of Birmingham |
Sector | Academic/University |
Country | United Kingdom |
Start | 08/2018 |
Title | ATRIAL FIBRILLATION THERAPY |
Description | The present invention relates to methods of selectively determining suitable treatments for subjects suffering from atrial fibrillation, as well as a method of administering an antiarrhythmic drug to a subject and the use a sodium channel blocker, such as flecainide or propafenone to treat a specific cohort of patients with atrial fibrillation. The present invention is based upon studies carried out by the present inventors into the effect reduced pitx2c expression has on response to antiar |
IP Reference | EP3120149 |
Protection | Patent granted |
Year Protection Granted | 2017 |
Licensed | No |
Impact | n/a |
Title | BIOMARKERS OF TRAUMATIC BRAIN INJURY |
Description | n/a |
IP Reference | EP3426796 |
Protection | Patent application published |
Year Protection Granted | 2019 |
Licensed | No |
Impact | n/a |
Title | COMPOSITION AND METHOD FOR BONE PRODUCTION |
Description | The present invention relates to extracellular vesicles derived from osteoblasts or osteoblast-like cells, and in particular to their use in promoting bone growth and repair. |
IP Reference | WO2018115871 |
Protection | Patent application published |
Year Protection Granted | 2018 |
Licensed | No |
Impact | n/a |